⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21805102 | 1.00 | — | — | |
| SCHEMBL12834637 | 0.82 | — | — | |
| SCHEMBL933250 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL551983 | 0.79 | — | — | |
| SCHEMBL13849697 | 0.79 | CHRM2 (0.50) | — | |
| SCHEMBL18433818 | 0.79 | CHRM2 (0.50) | — | |
| SCHEMBL15789500 | 0.77 | ALDH1A1 (0.31) | — | |
| SCHEMBL27691983 | 0.76 | MAPT (0.39) | — | |
| Propane SCHEMBL28654061 | 0.75 | ALDH1A1 (0.36) | — | |
| SCHEMBL30273471 | 0.74 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339514-A1 | SINGLE-AND MULTI-EPITOPE PEPTIDE AND MRNA VACCINES TO GENERATE TOLEROGENIC EFFECTS FOR ALLERGIC AND AUTOIMMUNE DISEASE BY TARGETING LIVER SINUSOIDAL ENDOTHELIAL CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-06 | — | — | US | claimed |
| CN-119894503-A | Lipid Nanoparticle (LNP) compositions or formulations for nucleic acid therapy | 波珀瓦克斯私人有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119654139-A | RNA Lipid Nanoparticles (LNP) comprising poly oxazoline polymer and/or poly oxazine polymer | 生物技术公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119654167-A | Nucleic acid compositions comprising amphiphilic oligoethylene glycol (OEG) conjugated compounds and methods of using such compounds and compositions | 生物技术公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119053696-A | Transmembrane receptor gene editing | 奥泽生物疗法公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118871586-A | Gene editing for improving joint function | 奥泽生物疗法公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118284645-A | Polyethylene glycol lipid containing lysine nucleus | 厦门赛诺邦格生物科技股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-118265522-A | Lipid-based RNA formulations suitable for treatment | 生物技术欧洲股份公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118201605-A | POEGMA-based lipid nanoparticles | 杜克大学 | 2024-06-14 | — | — | CN | claimed |
| CN-118079009-A | Lung-targeting polymer-lipid composition, nucleic acid delivery composition, preparation method and application thereof | 中国科学技术大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117510830-A | Pegylated lipid and modified liposome thereof, pharmaceutical composition containing liposome and preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117327270-A | Pegylated lipid and modified liposome thereof, pharmaceutical composition containing liposome and preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2024-01-02 | — | — | CN | claimed |
| CN-117304473-A | Pegylated lipid and modified liposome thereof, pharmaceutical composition containing liposome and preparation and application of pharmaceutical composition | 厦门赛诺邦格生物科技股份有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117241780-A | Biological delivery system | 帕帝塞拉公司 | 2023-12-15 | — | — | CN | claimed |
| CN-114286671-A | Compositions and methods for biological delivery vehicles | DNALite治疗学公司 | 2022-04-05 | — | — | CN | claimed |
| EP-3852728-A1 | PREPARATION OF LIPID NANOPARTICLES AND METHODS OF ADMINISTRATION THEREOF | Modernatx, Inc. (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020061457-A1 | PREPARATION OF LIPID NANOPARTICLES AND METHODS OF ADMINISTRATION THEREOF | MODERNATX, INC. (US) | 2020-03-26 | — | — | WO | claimed |
| WO-2009088891-A1 | SCREENING METHOD FOR SELECTED AMINO LIPID-CONTAINING COMPOSITIONS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2009-07-16 | — | — | WO | claimed |
| CN-122070139-A | Composition for preventing or treating bladder cancer | 基因特力株式会社 | 2026-05-19 | — | — | CN | disclosed |
| WO-2002010158-A2 | 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA | F. HOFFMANN-LA ROCHE AG (CH) | 2002-02-07 | — | — | WO | disclosed |